David Young
President & CEO at Processa Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Processa Pharmaceuticals Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Processa Pharmaceuticals Inc. July 30, 2026100.0%
-
Processa Pharmaceuticals Inc. July 18, 2025100.0%
-
Processa Pharmaceuticals Inc. June 28, 2024100.0%
-
Processa Pharmaceuticals Inc. June 27, 2023100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 30, 2026 | Processa Pharmaceuticals Inc. | Open-market purchase | +2,531 | $1.93 | $4,885 |
| Jun 15, 2026 | Processa Pharmaceuticals Inc. | Open-market purchase | +2,067 | $2.22 | $4,589 |
| May 29, 2026 | Processa Pharmaceuticals Inc. | Open-market purchase | +1,786 | $2.57 | $4,590 |
| May 15, 2026 | Processa Pharmaceuticals Inc. | Open-market purchase | +1,545 | $2.97 | $4,589 |
| Apr 30, 2026 | Processa Pharmaceuticals Inc. | Open-market purchase | +1,706 | $2.69 | $4,589 |
| Apr 15, 2026 | Processa Pharmaceuticals Inc. | Open-market purchase | +1,545 | $2.97 | $4,589 |
| Mar 31, 2026 | Processa Pharmaceuticals Inc. | Open-market purchase | +1,810 | $2.54 | $4,597 |
| Jan 1, 2026 | Processa Pharmaceuticals Inc. | Option exercise | +49 | — | — |
| Apr 1, 2025 | Processa Pharmaceuticals Inc. | Option exercise | +17,272 | — | — |
| Apr 1, 2025 | Processa Pharmaceuticals Inc. | Shares withheld for tax | −5,345 | $0.41 | $2,191 |
| Jan 27, 2025 | Processa Pharmaceuticals Inc. | Open-market purchase | +124,500 | $0.80 | $99,600 |
| Jul 10, 2024 | Processa Pharmaceuticals Inc. | Option exercise | +644 | — | — |
| Jul 10, 2024 | Processa Pharmaceuticals Inc. | Shares withheld for tax | −282 | $1.71 | $482 |
| Apr 5, 2024 | Processa Pharmaceuticals Inc. | Option exercise | +1,675 | — | — |
| Apr 5, 2024 | Processa Pharmaceuticals Inc. | Shares withheld for tax | −518 | $2.79 | $1,445 |
Questions about David Young
What boards is David Young on?
David Young sits on the board of Processa Pharmaceuticals Inc.
What company is David Young the CEO of?
David Young is President & CEO of Processa Pharmaceuticals Inc.
How long has David Young served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.